Compounded Semaglutide Providers That Accept HSA: 10 Compared (2026)

By the WPG Editorial Team · Updated and last verified: August 26, 2026

We don't have a medical reviewer on staff, so we don't claim one. A licensed clinician should make your medical decisions—not a website.

Affiliate disclosure: We may earn a commission if you use a provider link on this page. It never changes your price. Where a provider lands here is based on what we could verify about HSA payment, paperwork, cost, cancellation terms, and public regulatory records—not on what pays us. Some options on this page pay us nothing at all, and we say so. Full disclosure →

The short answer

Compounded semaglutide providers that accept HSA can let you pay with HSA money, but the card working does not prove the expense qualifies. Compounded semaglutide may be a qualified medical expense when a licensed clinician prescribes it as medical care for a condition a physician diagnosed and your records show what you bought and why. The provider, card network, and HSA custodian do not make the final federal tax decision for you.

For most people who have already decided with a clinician that compounded semaglutide is appropriate, Embody is the practical low-exposure pick. It advertises $79 a month on the monthly plan, with no separate membership fee. Over 90 days, that is $237. Embody charges the first payment at checkout, and its public terms say medication not yet dispensed may be refunded if a licensed provider finds you medically ineligible.

SHED is the paperwork-first pick. Its product page lists $199 for one month, $179 a month on a six-month plan, and $159 a month on a 12-month plan. Its terms separately say there is a two-month minimum, so confirm the first commitment in writing. It is the only provider in this audit with a full public workflow that says it accepts HSA/FSA cards, tells members where to download a detailed receipt, separates stronger and weaker expense categories, and gives a route to ask for more documentation.

Three things change the answer. If your file does not show a physician-diagnosed condition and a medical purpose, you may not be able to prove the expense qualifies. If you prepay for care or medication that will be provided much later, the timing becomes harder to document. And here is the part almost nobody tells you:

An HSA can let a weak expense file sit quietly for years.

A card processor may approve or decline the charge, but that is a payment decision. Your HSA custodian reports distributions. You report whether they were qualified on your tax return. If the IRS later treats a distribution as nonqualified, the amount is generally taxable and can also face a 20% additional tax when you are under 65.

So the real question is not only which provider takes your card. It is which provider leaves you with a file you can explain later. We built this page to answer that question.

Quick picks—the first screen

Prices are what the companies published or advertised on August 26, 2026. A modeled 90-day cost assumes the shown rate holds for three months unless the table says otherwise. Confirm your exact charge, dose price, commitment, and refund terms at checkout before you pay.

Which compounded semaglutide providers that accept HSA are best in 2026?

Answer: We found 10 active telehealth paths that publicly describe HSA or FSA payment or reimbursement for a compounded semaglutide program: Embody, SHED, Patiently by HSA Store, PlexusDx, Willow, TrimRx, Ivim Health, MEDVi, SkinnyRx, and Hims/Hers. Their processes are not the same. Some say an HSA debit card can be used at checkout. Some tell you to pay another way and reimburse yourself. Only a few publish what documents you can get.

Compounded semaglutide is not FDA-approved. The FDA does not review a compounded drug for safety, effectiveness, or quality before it is marketed. A licensed clinician must decide whether a compounded drug is appropriate for you, and FDA says patients should fill compounded prescriptions at a state-licensed pharmacy.

Here is every active provider path we checked, scored on the things that decide whether your HSA file is easy or hard to defend—not on whether a website shows an HSA badge.

The 2026 HSA audit

Excluded from the 10-provider count: Yucca Health says many patients use HSA/FSA funds, but its own FAQ says it does not provide itemized receipts or letters of medical necessity. We cover that exclusion below.

FDA-approved comparator: Ro does not accept HSA/FSA cards, but its FAQ says a detailed receipt is available. Its membership is $39 for the first month, then $149 monthly or as low as $74 per month with an annual prepay. Medication is separate.

How to read this table

The payment-path column is convenience. It does not decide tax treatment.

The receipt, medical-purpose record, bill structure, and cancellation columns tell you whether the file will be clear. And “verify” is not a compliment. Unknown never counts in a provider's favor.

What our labels mean:

• Stated in help center or at checkout — we found it in the company's current published material.
• Provider-stated — the company makes the claim on its own page. We did not test the card or request the document.
• No public workflow found — we searched the public site and did not find a process. That is different from “the company will not provide it.”
• Verify — we could not confirm it from public material. Ask in writing before paying.
• Regulatory record — a public FDA warning letter or National Advertising Division action tied to the provider. A warning letter is not a recall, shutdown, or court judgment.

You've seen the field. Here is the fastest way to act on it.

Embody has the lowest month-to-month price we found and the smallest three-month cash exposure. That does not make its paperwork the best. It makes it the practical price-first choice for a person whose clinician has already decided compounded treatment is appropriate and who is willing to request the documents.

→ Check eligibility and confirm Embody's current price

Embody says the initial charge occurs at checkout. Its terms say medication not yet dispensed may be refunded if a licensed provider finds you medically ineligible.

The honest problem with our top pick

Answer: Embody does not publish a receipt process or a medical-necessity-letter process on its public site. For someone who wants the documentation path confirmed before handing over a card, that is a real gap, and SHED is the stronger choice. Embody's advantage is cost: $79 per month on the monthly plan versus SHED's $199 one-month price.

We're not going to soften this.

We searched Embody's public site for a receipt workflow. We did not find one. We looked for a stated process for a medical-necessity letter. We did not find that either. SHED publishes both a detailed-receipt path and a route to ask for more documentation, and it is not close.

So here is the trade, plainly.

Embody does not spell out its paperwork process in advance. If that is your priority, SHED is stronger. SHED tells members which categories it labels eligible with a receipt, which categories may need more documentation, and where to download the receipt.

Embody publishes a much lower month-to-month price: $79 instead of SHED's $199 one-month price. On those one-month rates, 90 days is $237 instead of $597—a $360 difference. SHED's six- and 12-month plans lower its monthly equivalent to $179 or $159, but they also create a bigger commitment.

We do not know why Embody prices the program lower, and we are not going to invent a reason.

Here is what you can do: build a clean file around records the provider and prescriber actually issue. You can request a detailed receipt, prescription copy, visit summary, and chart note. You cannot turn a weak invoice into an official medical receipt by typing your own. The free file kit below gives you the exact messages to send, but the provider still has to supply the records.

If you would rather know the public workflow before paying, that is a completely fair call. Go with SHED.

→ See SHED's current pricing and documentation options

SHED's help center explains card use, receipt downloads, and which parts of its bill may need more proof.

What does “accepts HSA” actually mean?

Answer: “HSA eligible” is used to mean four different things that are not the same. It can mean the expense may fit federal tax rules, the checkout may process an HSA debit card, the company may give you useful records, or the company simply believes the program is eligible. A provider can be accurate about one and silent on the other three.

This is the single biggest source of confusion in this category, and once you see it, you cannot unsee it.

The four claims hiding inside one badge:

1. “The federal tax rules may be satisfied.” This depends on the medical purpose, the diagnosed condition, the prescription, the lawfulness of the care, and your records—not on the badge.
2. “Our checkout may process an HSA card.” This is payment plumbing. It does not prove the distribution is qualified.
3. “We will give you records you can use.” This is about the company's back office. This is the claim that protects you later, and it is the one many providers do not publish.
4. “Your account will approve it.” An FSA administrator often reviews a claim. With an HSA, your custodian may process the payment or reimbursement, but you remain responsible for the tax treatment you report.

A company can say “HSA/FSA accepted” and mean only number two. That may describe the checkout correctly. It is not the full promise a buyer may hear.

Three things you should never treat as proof that your expense qualifies:

• An HSA badge on a marketing page
• A support agent saying that customers use HSA cards all the time
• An article like this one

We can tell you what the IRS rules say, what the FDA says, what each company publishes, and where the gaps are. We cannot decide your personal tax result. Your medical purpose and your records do that work.

For the broader category, see our GLP-1 providers that accept HSA guide. If you have an FSA instead, use the separate semaglutide FSA guide, because the deadlines and claim-review process are different.

What does your receipt actually have to say?

Answer: The IRS does not publish a special five-box compounded-semaglutide receipt form. It does require you to keep records sufficient to show that an HSA distribution paid a qualified medical expense, was not reimbursed from another source, and was not also taken as an itemized deduction. In practice, a useful receipt should identify the patient, date, medical item or service, seller, and amount. A card statement by itself usually does not show enough medical detail.

WPG's five-field receipt test

This is our practical evidence test, not an official IRS checklist. Run it on any receipt you already have. It takes 60 seconds.

Field three is where compounded telehealth often gets murky.

Many programs bill one flat monthly charge. The description may say “Monthly Plan,” “Weight Loss Program,” or only the company name.

A program is not a drug. A plan is not a drug.

That description may still be explainable with the prescription, visit record, and a better invoice. But “Weight Loss Program—$199” does not tell a tax reviewer what was purchased. IRS Publication 502 says the cost of a weight-loss program is a medical expense only when the program treats a specific disease diagnosed by a physician, such as obesity, hypertension, or heart disease—not when the purpose is appearance, general health, or well-being.

Ask for the medication and medical services to be identified before you need the record. If the company cannot change the invoice, ask for a separate paid-receipt letter or account statement that connects the charge to the prescription and services.

Why split billing is usually easier to defend

This is backwards from what most people assume, so stick with us.

A single all-in charge sounds simpler. It can be harder to explain. If the bundle contains prescription medication, a clinical visit, coaching, supplements, and a general wellness service, you may need to show which parts were medical care and how the total was allocated.

A split receipt lets the prescription and clinical-care lines stand on their own. It does not automatically make every line qualified, but it gives you cleaner proof.

This is why SHED's help center is useful. SHED says prescription supplies, provider visits, and shipping are eligible with a receipt, while coaching charges and supplements may need additional documentation. That is the provider's own description—not an IRS ruling—but it tells you how SHED structures and documents the bill.

Do you need a letter of medical necessity?

Not automatically for every HSA expense. An HSA does not use the same routine claim-review process as an FSA. But a clinician's letter or chart note can be valuable when the receipt and prescription do not make the diagnosed condition and medical purpose clear.

A useful supporting note names:

• The patient
• The condition being treated
• The treatment recommended
• The expected treatment period, when relevant
• The clinician's name, credentials, date, and signature or authenticated chart entry

For compounded semaglutide, also ask the prescriber to record the patient-specific reason the compounded version was chosen. That note helps explain the clinical decision. It does not by itself prove that every act by a pharmacy or platform complied with compounding law.

Ask while you are still a customer. Records are harder to chase after you cancel.

Build your HSA file in about ten minutes

You do not need to type your diagnosis into a website. Use this page as the tool.

1. Save this document checklist

• Prescription or prescription copy
• Detailed receipt or paid invoice
• Proof of payment
• Visit summary or chart note showing the diagnosed condition and medical purpose
• Prescriber note explaining why a compounded version was selected, when relevant
• Pharmacy name, address, and state-license lookup result
• Product label showing the exact formulation and concentration
• Cancellation confirmation and any billing emails
• A note showing that the expense was not reimbursed elsewhere and was not also deducted

2. Send this message to the provider

Subject: HSA records request

I am keeping records for a possible HSA reimbursement. Please send a paid, itemized receipt or account statement that shows my name, the date, the medication and medical services provided, the provider or dispensing pharmacy, and the amount paid. Please list the prescription charge, clinical-care charge, membership charge, coaching, supplements, shipping, and any other charge separately when possible. Please also tell me where I can download future receipts and whether there is a fee for copies of my prescription or medical record.

3. Send this message to the prescriber

Please make sure my chart states the condition being treated, the medical purpose of the prescription, and the patient-specific reason a compounded formulation was selected instead of an available FDA-approved product. Please send me a copy of the visit summary or relevant chart note for my records.

4. Keep one running record

5. Calculate your federal exposure

Use this simple model:

• Federal income-tax value of a qualified HSA expense: expense × your federal marginal rate
• Modeled federal tax if the distribution is nonqualified and you are under 65: expense × (your federal marginal rate + 20%)

This does not include state tax, interest, an accuracy-related penalty, or payroll-tax treatment. It is a planning model, not a tax return.

Your HSA card got declined. Now what?

Answer: A declined HSA card is a payment problem, not a federal tax ruling. A decline can come from merchant coding, the card network, account limits, insufficient HSA funds, or the custodian's rules. Pay another way and reimburse yourself later only after you are comfortable that the expense qualifies and you have the records. Federal HSA rules do not impose a deadline for that reimbursement.

Here is the six-step version:

1. Save the decline details. Keep the merchant name, amount, date, and any error message.
2. Do not treat the decline as a medical or tax answer. It only tells you the payment did not process.
3. Call your HSA custodian and ask for the exact decline reason and its reimbursement steps.
4. Pay with a regular card only if you can afford to float the charge. Do not create a cash-flow problem to chase a tax benefit.
5. Get the itemized receipt and medical records. Do this before reimbursing yourself.
6. Reimburse yourself from the HSA when you are satisfied the expense was incurred after the HSA was established, is qualified, was not reimbursed elsewhere, and was not also deducted.

One thing we want to say directly, because this question is often answered as if cash flow does not matter:

You should not have to front a large multi-month charge and hope the file works later. If cash is tight, that is not a small detail. It is the decision. Pick a provider that states HSA-card acceptance, or choose a month-to-month price you can safely float. Willow and SHED state card acceptance. Embody's monthly charge is $79, but its public receipt process is not spelled out.

The HSA advantage almost nobody mentions

Here is the part that should genuinely relax you.

Federal HSA rules do not set a deadline for paying yourself back.

IRS Notice 2004-50 says an account beneficiary may defer an HSA reimbursement to a later year if the expense happened after the HSA was established and the required records are kept. You can pay out of pocket now and reimburse yourself years later. You do not get to reimburse the same expense twice or also claim it as an itemized deduction.

FSA plans usually work around a plan year, run-out period, grace period, or carryover rule. An HSA has a different clock.

The reimbursement does not expire under the federal rule. Your proof can disappear if you lose it.

That one sentence is the whole reason this page exists.

What happens if an HSA distribution is not qualified?

Answer: A nonqualified HSA distribution is generally included in taxable income. IRS Publication 969 also adds a 20% additional tax when you are under 65, unless an exception such as disability or death applies. On a $2,388 year—12 months at $199—that produces about $1,003 of modeled federal income tax and additional tax at a 22% marginal rate. A qualified distribution has no federal tax on the withdrawal. The contribution's original tax treatment is the same starting point in both cases, so it must not be counted a second time when comparing qualified and nonqualified use.

We're going to show you the math, because the result is much easier to understand when you can see it.

What the federal tax difference looks like

The example: a $199 monthly program for 12 months. $2,388 total.

* Expense multiplied by the marginal federal rate, assuming the HSA contribution was deductible or excluded from income and the distribution is qualified. This is the federal income-tax value of using tax-advantaged HSA dollars for the expense, not necessarily a refund received today.

** Expense multiplied by the marginal federal rate plus the 20% additional tax. State tax, interest, and other possible tax consequences are not included.

*** The contribution's original deduction or exclusion is held constant in both scenarios. The difference is therefore the federal tax that applies to the nonqualified distribution—not that amount plus the original contribution benefit.

At a 22% bracket, the difference between qualified and nonqualified treatment is about $1,003 on a $2,388 distribution. That is about 42 cents for every dollar distributed in this model.

The math, so you can check us:

• Qualified distribution tax: $0
• Nonqualified distribution income tax: $2,388 × 22% = $525.36
• Additional tax: $2,388 × 20% = $477.60
• Qualified-vs.-nonqualified difference: $525.36 + $477.60 = $1,002.96

One possible benefit we left out of the table: employee HSA contributions made through a cafeteria-plan salary reduction may also avoid Social Security and Medicare payroll taxes. For a worker subject to the full employee rate, that can be 7.65%, or about $183 on $2,388. It does not apply to every contribution or every worker, so we did not count it in the main table. State treatment also varies.

Never trust a page that promises one flat percentage for everyone. Your result depends on your income, state, funding method, and whether the distribution is qualified.

Now run it on the cheap option

Same model on Embody's $79 monthly price—$948 for a year:

• Federal income-tax value at 22% if qualified: about $209
• Modeled federal income tax plus 20% additional tax if nonqualified: about $398
• Qualified-vs.-nonqualified difference: about $398

That is the honest HSA-specific case for the cheaper monthly program. It is not that Embody's public paperwork is better. It is not. It is that the amount of money exposed—and therefore the modeled federal tax on a nonqualified distribution—is smaller.

Who handles what, and when

• At checkout: the merchant, card processor, and custodian may approve or decline the payment. That is not a final tax ruling.
• Each year: the HSA trustee or custodian reports distributions on Form 1099-SA.
• On your tax return: you report HSA distributions and qualified expenses on Form 8889.
• If the IRS asks: you may need to produce the records supporting the qualified expense.

That is the system. The freedom is real. So is the recordkeeping job.

Is compounded semaglutide still legal in 2026?

Answer: Compounded semaglutide is not categorically illegal in 2026, but the broad shortage-era path is over. The FDA declared the semaglutide injection shortage resolved on February 21, 2025. The practical 503A enforcement-discretion period ended on April 24, 2025 after a federal court ruling, and the 503B shortage-based period ended on May 22, 2025. A 503A pharmacy may still compound for an identified patient under a valid prescription, but federal restrictions on making regular or inordinate amounts of products that are essentially copies still apply. A prescriber-documented change that produces a significant difference for that patient can matter.

This is the section we would most want a friend to read before using HSA money.

Quick definitions, because these two numbers get thrown around constantly:

• A 503A compounder is a state-licensed pharmacy or physician that compounds under the conditions in section 503A, generally for an identified individual patient based on a valid prescription. Section 503A restricts regular or inordinate compounding of products that are essentially copies of commercially available drugs.
• A 503B outsourcing facility is an FDA-registered facility that may compound in batches if it meets section 503B's conditions. When it compounds from bulk drug substances, the substance generally must be on the 503B bulks list or the compounded drug must be on the FDA shortage list at the required times. Semaglutide is on neither list as of this verification date.

What changed, and when

One part of the 503B proposal deserves your attention: FDA said supply problems, convenience, and cost did not establish the kind of clinical need it was evaluating for the bulks list.

Read that carefully. It means “it is cheaper than Wegovy” is not, by itself, the 503B clinical-need case FDA was asking for. The proposal is not a final rule, and it is not an IRS ruling. It does show how narrowly FDA is analyzing mass production from semaglutide bulk drug substance.

What may still fit under 503A?

For an identified patient, a prescriber may determine and document that a change in the compounded product creates a significant difference from an available commercial product. Depending on the facts, that could involve:

• An inactive ingredient the patient cannot use
• A strength or dose presentation that creates a meaningful patient-specific difference
• A formulation or route that creates a meaningful patient-specific difference
• Another documented clinical feature that is genuinely significant for that patient

A note that only says “cheaper” is not the same thing as a documented significant clinical difference.

And the prescriber's note is not the whole legality question. The pharmacy, ingredients, formulation, prescription, amount compounded, and other facts still matter.

Why this lands in an HSA file

Here is the connection almost nobody makes.

IRS Publication 502 excludes amounts paid for illegal operations or treatments, even when a licensed practitioner performs or prescribes them. We found no IRS guidance that applies that sentence specifically to compounded semaglutide after the shortage.

So this is our evidence-based conclusion, not an IRS semaglutide ruling:

Lawfulness is a recordkeeping risk flag. It is not a reason to declare every patient-specific compounded semaglutide prescription nonqualified.

A prescription alone does not prove every part of the supply chain was lawful. A clean file should show the clinical reason for the compounded version, the dispensing pharmacy, and the actual formulation.

What to do—two minutes of work:

Ask your prescriber to record the patient-specific reason the compounded product creates a significant difference for you. Save the visit note. Then confirm the pharmacy's legal name, state license, and the exact formulation on the label.

That does not create legality by itself. It gives your file the facts that explain the decision.

What we are not saying: we are not saying all compounded semaglutide is illegal. We are not telling you to stop a medication. We are telling you that broad shortage-based copying ended, the remaining rules are narrower, and your HSA custodian may never warn you that your file is thin.

If that gave you pause, that is a reasonable reaction—and there is a cleaner regulatory alternative.

An FDA-approved semaglutide product does not carry the same compounded-drug approval and copy-rule questions. Ro offers FDA-approved GLP-1 options, a free insurance coverage checker, and an insurance concierge that handles prior-authorization paperwork when applicable. Ro does not accept HSA/FSA cards, but its FAQ says you can submit a detailed receipt to your HSA provider.

Ro Body costs $39 for the first month, then $149 a month on the monthly plan or as low as $74 a month with an annual prepay. Medication is billed separately.

→ See Ro's current pricing and free coverage checker

The coverage check is free. Ro says the membership charge begins only if you are eligible for treatment; medication cost is separate.

For an HSA-specific look at the approved brand, see our Wegovy HSA guide.

What does compounded semaglutide really cost after month one?

Answer: The advertised monthly number is not enough. The useful numbers are the first charge, the cash you commit today, the modeled 90-day cost, and the last day you can cancel without another charge. Among the options with enough public pricing to model, three-month equivalents run from $228 on Embody's quarterly tier or $237 month to month to $897 at Willow's published starting rate. Hims/Hers has a $597 three-month equivalent at its advertised compounded rate, but the six-month medication plan is paid in full, so the upfront medication charge is about $1,194.

Advertised prices in this category often belong to a longer commitment. Here is what that looks like.

Embody's price ladder—this explains the confusion

If you have searched Embody, you may have seen $69, $79, $99, $149, $199, or $299 described as “the price.” Embody's current terms list a new active program and also preserve older programs that they mark no longer active.

Embody's terms say bundled-plan customers remain responsible for the current commitment period and unused portions are generally not refunded, except where required by law or when treatment is not approved or medical necessity supports a refund. Confirm the exact checkout charge and shipment cadence before selecting a bundle.

On an HSA, the monthly plan is often the cleaner recordkeeping choice even though it costs $10 more per month than the annual equivalent.

Why? IRS Publication 502 limits deductions for medical care paid substantially before the care is received. That publication is written for medical-expense deductions, and the IRS has not published a compounded-telehealth HSA prepay example. Still, a long prepay creates a harder timing and allocation question than one charge tied to one month of care and medication.

That does not make every annual plan nonqualified. It makes month-to-month easier to explain.

Ten dollars a month for cleaner timing and a smaller commitment can be cheap.

The 90-day comparison

WPG calculations use public prices displayed or described on August 26, 2026. They may exclude dose changes, memberships where applicability is unclear, add-ons, labs, taxes, or later price changes. “Equivalent” is not the same as cash due today.

Three things are worth pausing on. First, SHED's $159 and $179 prices belong to longer plans. The monthly equivalent is lower, but the total commitment is larger. Second, Willow says the price starts at $299 and varies by dose and prescription, so $897 is a floor model, not a promise. Third, TrimRx's terms say cancellation does not automatically trigger a refund. That does not prove bad conduct. It is a contract term you should understand before paying.

Set your cancellation-review date now

Do this before you close the tab:

1. Find the next billing or shipment date in the portal.
2. Use the provider's published cutoff.
3. Put a calendar reminder five business days before the cutoff, not on the cutoff.
4. Add the words: “Review price, dose, remaining supply, receipt, and next charge.”

A reminder is not pressure to cancel. It gives you a quiet moment to make the choice before the system makes it for you.

Ready to move?

Embody's $79 monthly plan has the lowest three-month cash exposure we found among the active options with public month-to-month pricing. Its public paperwork process is the weakness. The smaller charge and shorter commitment are the strength.

→ Check Embody eligibility and see the live checkout terms

Initial charge occurs at checkout. Save the terms, ask for the receipt workflow, and confirm the cancellation date before enrolling.

Provider breakdowns

Embody—lowest month-to-month cost, least cash exposed

The punchline: Embody has the cheapest active month-to-month price we found, no separate membership fee, and no FDA warning letter we located under Embody, JoinEm, or Modern Metabolic Medicine. The gap is documentation, and it is a real gap.

What it costs: Embody's current terms list semaglutide at $79 monthly, $76 per month on a quarterly plan, $73 per month on a six-month plan, and $69 per month on a 12-month plan. The first charge happens at checkout. Bundled plans carry the full selected commitment. The current active program says there are no price increases on the listed plans.

What we could verify:

• Embody advertises HSA/FSA eligibility on its own site
• The current active semaglutide program starts at $79 per month
• There is no separate membership fee advertised
• The initial charge happens at checkout
• Its terms say medication not yet dispensed may be refunded when a licensed provider finds the patient medically ineligible
• It publicly names Red Rock Pharmacy, HealthWarehouse, Precision Compounding Pharmacy, and Triad Rx as pharmacy partners
• Medical treatment is provided through the OpenLoop Health network
• Modern Metabolic Medicine, Inc. is the legal entity operating Embody/JoinEm

What we could not verify: whether Embody automatically issues a receipt that names the medication and medical services, whether it will provide a medical-necessity letter or equivalent chart note on request, and which of its two public cancellation cutoffs controls. Its main terms say five days before the prescription period ends. Its refund page says 72 hours before the billing date. Use five days unless Embody gives you a later rule in writing.

Who it is wrong for: anyone who needs the documentation workflow confirmed publicly before paying. Go to SHED.

Compounded semaglutide is not FDA-approved. It is not a generic version of Ozempic or Wegovy, and it is not interchangeable with them.

→ Check eligibility on Embody — the first charge happens at checkout; review the refund and cancellation terms first

SHED—the clearest public paperwork workflow

The punchline: SHED is not the cheapest one-month option. It is here because its help center does something no other provider in this audit does as fully: it tells you how HSA/FSA payment works, where the receipt is, and which kinds of charges may need more proof.

What it costs: SHED's current product page lists $199 for one month, $179 per month on a six-month plan, and $159 per month on a 12-month plan. Its terms separately say every program has a two-month minimum and list a $199 standard monthly rate after a multi-month term ends. Those public pages do not fit together perfectly. Treat the two-month minimum as controlling unless SHED confirms a true one-month option in writing. Longer plans lower the monthly equivalent but increase the amount of time and money you commit.

Cancellation must be submitted at least 72 hours before the next billing date or scheduled shipment.

What its own help center states:

• It accepts HSA and FSA cards for prescription purchases
• Prescription supplies, provider visits, and shipping are described as eligible with a receipt
• Coaching charges and supplements may need additional documentation
• A detailed receipt is available in the member portal
• It publishes the steps for finding and downloading the receipt
• Members who need more documentation can contact SHED for help

Those are provider statements, not a private IRS ruling. What makes them valuable is that they tell you what the company will document before you enroll.

The honest trade: at the one-month rates, SHED is $360 more than Embody over 90 days. Its longer plans cut that gap, but they create a much larger commitment. You are paying more—or committing longer—for the public documentation path.

Who it is wrong for: anyone who needs a one-month price below $199 or cannot accept a multi-month commitment.

→ See SHED's current pricing and documentation options

Patiently by HSA Store—the HSA-focused checkout, not zero paperwork risk

We earn nothing from this recommendation. We are including it because it may be the right answer for a specific person.

Patiently is offered by FSA Store/HSA Store, so the shopping path is built around tax-advantaged health accounts. Its weight-loss program advertises a first-time monthly price starting at $199 and no membership fee.

That does not make the tax result automatic.

Patiently's own cancellation and refund policy says:

• HSA/FSA reimbursement depends on the customer's circumstances and plan requirements
• Reimbursement is not guaranteed
• Enrollment does not guarantee a prescription
• A clinician deciding not to prescribe is not, by itself, a refund reason
• Medication charges are nonrefundable once dispensed
• A denied claim may qualify for a separate eligibility guarantee only if its stated conditions are met

That is not “zero paperwork risk.” It is an HSA-focused merchant with a clearer payment context and its own limits.

We could not verify the exact receipt format, a medical-necessity-letter process, the dispensing pharmacy for every plan, or the true 90-day charge. Ask before paying.

Who it is right for: someone who values an HSA-centered checkout and is willing to read the guarantee and refund terms before enrolling.

→ See Patiently's current weight-loss options (nonaffiliate)

PlexusDx—specific paperwork claims that still need testing

The punchline: PlexusDx makes the most specific provider-stated paperwork claims after SHED, but those claims come from PlexusDx itself and we did not test them.

What it costs: PlexusDx publishes compounded semaglutide injection at $189 month to month or $149 per month on a six-month plan, with no membership fee stated.

What PlexusDx says it provides:

• HSA-card payment at checkout where the HSA administrator permits it
• Itemized receipts for reimbursement
• A prescription-verification or supporting letter on request
• No separate membership fee

Those are useful claims because they are concrete. They are not independent proof that your card will work or that your distribution qualifies. Ask PlexusDx to send a sample redacted receipt or confirm the fields in writing before paying.

Who it is right for: someone who wants a lower monthly price than SHED and is willing to verify the self-published documentation promises.

Ivim Health—where two of its own documents point in different directions

This one is worth reading even if you never use Ivim, because it shows you exactly what to look for everywhere else.

Ivim's pricing materials say an HSA or FSA card may be used for its compounded program.

Ivim's membership agreement says membership fees are not eligible for insurance reimbursement and cannot be submitted to a health plan or HSA without independent verification. It also says the membership is a program-access fee, not a purchase of a specific medication.

Both statements can be true. The medication expense may be easier to support than a general membership fee. But you need the bill split to see that.

Ivim's public pricing has described $379 for a two-month medication program and $499 for four months, with a free first month of membership followed by about $75 per month. Under that model, the first three months are about $649: $499 for the four-month medication program plus two $75 membership charges. The full four-month cost is about $724 when three paid membership months are included.

This is the bundled-versus-split problem in the wild. If the receipt separates medication from membership, you can evaluate each line. If it combines them, the proof becomes harder.

Ivim also received FDA Warning Letter #721816 on February 20, 2026. The letter addressed marketing and labeling representations that FDA said were false or misleading, including material that suggested Ivim had compounded or evaluated products when it was not the compounder.

A warning letter is not a recall or a finding that every service is unsafe. It is a public compliance record a buyer should see.

If you are considering Ivim, ask these five questions first:

1. Is the medication charge separate from membership on my receipt?
2. Does the receipt identify each service and medication?
3. Which portion are you representing as HSA eligible, and what is that statement based on?
4. Can I enroll without the membership fee?
5. What remains owed if I stop early?

We're not putting a signup button here. Read the written answers first, then decide.

→ Compare providers with clearer receipt itemization

Willow—the clearest direct-card language at a higher price

Willow says customers can use an HSA or FSA at checkout. Its program starts at $299 per month and includes medication, the medical evaluation and treatment plan, physician access, support, and shipping. Willow also says cost varies by dose and prescription, so $299 is a starting number, not a locked three-month promise.

Willow says cancellation requests must arrive at least two business days before the next processing date. It offers a full refund only when cancellation happens before the prescription is sent to the pharmacy.

At the published starting rate, 90 days is $897. That is $660 more than Embody's monthly plan and $300 more than SHED's $199 one-month rate over the same period.

Willow also has a public advertising record. The National Advertising Division referred a matter involving compounded-semaglutide claims to regulators in December 2025. After the matter was reopened, BBB National Programs reported in July 2026 that Willow had permanently discontinued the challenged claims. That record does not tell you whether your HSA expense qualifies. It belongs in the decision because it concerns how the product was marketed.

Best for: someone who values direct HSA/FSA checkout language and accepts the higher starting price.

TrimRx—low advertised price, but read the refund term

TrimRx advertises compounded semaglutide at $199 per month on some current pages, with no separate membership fee. Other TrimRx material describes a broader $199-to-$299 range, so confirm the exact dose and live checkout amount.

Its HSA claim is provider-stated. We did not find a public receipt or medical-necessity-letter workflow.

The term to read before paying: TrimRx says cancellation does not automatically result in a refund. A separate refund request may be needed, and eligibility depends on the terms and whether services or medication have been used or prepared.

That does not prove the company will mishandle a refund. It means “I canceled” and “my money is coming back” are not the same event.

Best for: someone who gets the $199 live price, confirms the paperwork in writing, and understands the cancellation/refund process before enrolling.

MEDVi—clear first-month discount, higher refills, FDA warning letter

MEDVi advertises compounded semaglutide at $179 for the first month and $299 for refills, with the program price covering the clinician review, plan, support, medication, and shipping. That makes the modeled first 90 days $777, not $537 and not $597.

MEDVi says HSA/FSA payment may be used. We did not find a full public receipt or medical-necessity-letter workflow.

Its cancellation policy requires notice at least 72 hours before the next billing date. A provider disqualification can trigger a refund, while services and medication already provided narrow the refund path.

MEDVi received FDA Warning Letter #721455 on February 20, 2026. FDA said MEDVi used false or misleading compounded-drug marketing and labeling representations, including imagery and statements that could imply approved-product identity or FDA evaluation.

That is not a recall. It is a reason to read current claims and labels carefully.

SkinnyRx—base price advertised, documents still unclear

SkinnyRx advertises HSA/FSA eligibility and compounded semaglutide starting at $199 per month. We could not verify a public receipt workflow or medical-necessity-letter process.

Its published terms describe a five-day cancellation window before renewal. Refund rights narrow once provider review and prescription fulfillment move forward, and dispensed medication cannot be returned.

SkinnyRx, legally Lean Rx, Inc., received FDA Warning Letter #717989 on February 20, 2026. The letter addressed false or misleading representations involving compounded drugs and approved-product-style imagery or claims.

At the base advertised rate, 90 days would be $597. Confirm the actual dose, price, charge date, and receipt before treating that as your number.

Hims/Hers—limited compounded access remains, but the cash commitment is large

Hims and Hers did not leave compounded semaglutide entirely. After FDA announced action in February 2026, Hims & Hers changed its U.S. strategy. Its March update said the company would focus on FDA-approved products while keeping limited compounded access for patients whose needs cannot be met by approved options.

What the current public pages say:

• Compounded semaglutide access starts at $199 per month on a six-month plan paid in full
• That is about $1,194 paid up front for the medication plan
• Hims/Hers recommends paying with a normal credit or debit card and downloading a receipt for HSA/FSA reimbursement
• Receipt-download steps are published
• Weight-loss membership and medication can be billed separately
• Cancellation is due at least two days before the next billing date
• Shipped medication is not refundable

A three-month equivalent is $597, but that hides the real cash decision. You may have to put about $1,194 at risk up front, before any membership that applies. That is the opposite of Embody's low-exposure argument.

Hims & Hers received FDA Warning Letter #716825 on September 9, 2025. FDA challenged marketing that compared compounded semaglutide with approved products in a false or misleading way.

Best for: someone already comfortable with Hims/Hers, willing to prepay, and able to confirm that the offered compounded plan fits the clinician-documented patient-specific path.

The caution lane

These companies have public FDA warning letters tied to compounded-drug marketing. A warning letter is not a recall, shutdown, or court judgment. It is FDA telling a company about identified violations or compliance concerns and asking for corrective action.

You can open every letter in the FDA warning-letter database. We link them in the source list below.

Notice what MyStart's letter was about: claims that called compounded semaglutide “generic Ozempic” or presented it as equivalent to an approved product. There is no FDA-approved generic semaglutide. If a company calls its compound a generic Ozempic or generic Wegovy, stop and verify everything else it says.

The one we cannot recommend for HSA use—and why

Yucca Health has one of the lowest public prices in this category. Its current price page shows $146 monthly, $420 for three months, and $750 for six months—equal to $125 per month on the six-month commitment.

Its own FAQ says Yucca does not provide itemized receipts or letters of medical necessity.

On a page about the file you keep, a provider that says it will not provide the core file cannot be an HSA recommendation. That is not a statement about its clinicians or the quality of a specific prescription. It is a direct answer to the documentation question.

A primary-care diagnosis note cannot fix a receipt that does not identify what you bought. Your own spreadsheet cannot turn a generic card charge into a provider-issued itemized receipt.

If you plan to use HSA funds, pick a provider that will document the charge. Yucca may still be a cash-pay option for someone who is not using an HSA, but it does not clear the documentation bar for this page.

How do you check the pharmacy before you pay?

Answer: Ask for the dispensing pharmacy's legal name, verify its state license, confirm the exact formulation and concentration, and ask whether the product uses semaglutide base rather than semaglutide sodium or semaglutide acetate. FDA says the salt forms are different active ingredients from the semaglutide used in approved drugs and that it is not aware of a lawful basis for using those salts in compounding.

Two safety items here have nothing to do with taxes and everything to do with you.

Ask whether it is semaglutide base

There are different chemical forms sold under the word semaglutide. FDA says semaglutide sodium and semaglutide acetate are salt forms and are different active ingredients from the semaglutide used in FDA-approved products.

The question to ask, word for word:

Does the pharmacy use semaglutide base—not semaglutide sodium or semaglutide acetate—and will that exact ingredient appear on my label or pharmacy record?

A clear provider should be able to identify the pharmacy and formulation. If the answer stays vague, do not guess.

Know your dose in milligrams, not only “units”

FDA has reported dosing errors with compounded injectable semaglutide. The core problem is confusion among milligrams, milliliters, and syringe units. FDA says some errors led to medical care or hospitalization.

Compounded products often come in a vial with a syringe instead of a factory-filled pen. Concentrations can differ between pharmacies or prescriptions.

Before the first injection, confirm all four items with the prescriber or pharmacist:

1. Your prescribed dose in milligrams
2. The vial concentration in mg/mL
3. The exact volume in mL for that dose
4. The matching mark on your specific syringe

Write the answer down. Compare it with the prescription label every time the vial, concentration, syringe, or dose changes. Do not redo the math from memory.

If the medication arrives warm when the label requires refrigeration, has broken packaging, lacks clear instructions, or names a pharmacy you cannot verify, contact the pharmacy and prescriber before using it.

The 10 questions to ask before you pay

Copy this. Send it to any provider you are considering. The answers—and how clearly the company gives them—will tell you more than an HSA badge.

1. Can I enter an HSA debit card directly at checkout, or do you recommend reimbursement?
2. Does my bill separate the prescription, clinical care, membership, coaching, supplements, shipping, and other fees?
3. Do you issue a paid, itemized receipt showing my name, date, medication or service, provider or pharmacy, and amount paid?
4. Can I get a prescription copy, visit summary, or clinician letter that states the diagnosed condition and medical purpose? Is there a fee?
5. What should I do if my HSA card is declined?
6. What is the exact cancellation deadline, and when does the charge become nonrefundable?
7. Which pharmacy will fill my prescription, and can I verify its license before paying?
8. Does the pharmacy use semaglutide base rather than semaglutide sodium or acetate?
9. Is the exact program available in my state?
10. What is the total cash amount I am committing to today, including membership, medication, labs, shipping, and future required payments?

Save the written reply. Date it. It becomes part of the record showing what you were told before paying.

Does your state change which provider you can use?

Answer: Yes. The treating clinician must be authorized to treat you where you are located, and the dispensing pharmacy must be able to lawfully dispense or ship the prescription to your state. Provider and pharmacy coverage can change, and a national-looking website does not mean every compounded program is offered in every state.

Do not rely on an old state list from a review page.

Check state availability during intake before the final payment step. Then ask which pharmacy will be used for your state. A platform may work nationally while a specific medication, pharmacy, or clinician network does not.

If a provider will not identify the dispensing pharmacy until after a nonrefundable charge, count that as a real decision cost.

Which compounded semaglutide provider that accepts HSA is right for you?

Answer: The choice comes down to four things: whether a clinician has diagnosed the condition being treated, whether a compounded product is clinically appropriate, how much paperwork you are willing to handle, and how much cash you are willing to expose at one time.

Four readers should leave the provider links alone for now, and we mean that as a service:

1. No diagnosed condition or medical purpose in the record. Get evaluated first. Weight loss for appearance or general well-being is not the same tax category as treatment for a physician-diagnosed disease.
2. No patient-specific reason for the compounded version. Ask the clinician whether an FDA-approved product can meet your needs and why the compounded option is being selected.
3. You cannot afford the first charge without the HSA reimbursement. Do not prepay six or 12 months and hope the paperwork works later.
4. You cannot get the pharmacy name, formulation, dose instructions, or itemized receipt. Those are not decorative details.

→ Check Embody · See SHED · Check FDA-approved coverage with Ro

How we checked this

Answer: Weight Loss Provider Guide is an independent comparison resource for GLP-1 telehealth providers. For this page, we reviewed each provider's current public help center, pricing page, terms, cancellation policy, or program page; checked the FDA warning-letter database by company and brand name; reviewed the current FDA compounding pages and Federal Register proposal; and calculated the tax examples from IRS Publication 502, Publication 969, Notice 2004-50, and the 2026 HSA limits in Revenue Procedure 2025-19.

Claims we could not independently test are labeled provider-stated, no public workflow found, or verify.

What we actually verified

Our evidence order, highest to lowest: government sources first, then the company's legal terms and refund policy, then its help center or checkout, then its marketing pages, then written provider statements. Reviews and forums can show what people worry about. They do not prove tax eligibility, safety, a typical result, or a regulatory fact.

On affiliate links: commission does not decide the conclusion. Patiently is linked directly without an affiliate link. PlexusDx has no signup link in this article. Yucca's low price could have made it an attractive recommendation, but we excluded it from the HSA list because its own FAQ says it does not provide the documents this page is about.

Found something that changed? Send us the provider, exact claim, source link or screenshot, and date. We update material corrections and change the visible verification date only when the page is actually rechecked.

What the public record says about paperwork and claims

Anonymous service-review quotes are not evidence for a tax or medical decision. A review can describe one customer's experience, but it should not carry this page unless the exact source, date, and original wording can be checked.

The verified public record gives you stronger evidence:

• SHED publishes a member-portal receipt path and distinguishes prescription supplies, visits, shipping, coaching, and supplements in its own HSA/FSA help article.
• Ivim says HSA/FSA payment may be used for the compounded program, while its membership agreement says membership fees need independent verification before submission to an HSA. That is a real document-level distinction.
• Willow was referred by the National Advertising Division over challenged compounded-semaglutide claims in December 2025. In July 2026, BBB National Programs said Willow permanently discontinued those claims after the matter was reopened.
• Embody publicly names its pharmacy partners and current prices, but we did not find a public receipt or medical-necessity-letter workflow.
• Yucca directly says it does not provide itemized receipts or medical-necessity letters. That one sentence is more useful for this decision than a star rating.

None of those facts proves a medication will be right for you. They show how much of the payment and documentation process is visible before you pay.

Common questions

Can I use an HSA card directly for compounded semaglutide?

Sometimes. SHED and Willow state direct HSA/FSA card acceptance. Embody, MEDVi, SkinnyRx, TrimRx, PlexusDx, and others make provider-stated HSA claims with different levels of detail. Hims/Hers recommends paying with a regular card and downloading a receipt for reimbursement. A card approval or decline does not decide federal tax eligibility.

Is compounded semaglutide a qualified medical expense?

It may be when it is lawfully prescribed as medical care for a physician-diagnosed condition and the records support the expense. IRS Publication 502 treats prescribed drugs and disease-directed weight-loss care differently from expenses for appearance or general well-being. The IRS has not published a compounded-semaglutide HSA ruling that blesses every program.

Does “not FDA-approved” automatically break my HSA claim?

No. Publication 502's prescribed-drug definition does not list FDA approval as a separate tax test. But compounded drugs are not reviewed by FDA before marketing, and Publication 502 excludes illegal treatments. The lawfulness, medical purpose, prescription, and records still matter.

Do I need a letter of medical necessity?

Not automatically for every HSA expense. Get a clinician's letter, visit summary, or chart note when the receipt and prescription do not clearly show the diagnosed condition and medical purpose. For a compounded product, ask the prescriber to record the patient-specific reason for the compounded version.

Does the membership fee count, or only the medicine?

The prescription and clinical-care lines are usually easier to explain than a general membership, coaching, or wellness fee. Ivim's own membership agreement says its membership fees cannot be submitted to a health plan or HSA without independent verification. Ask for separate line items.

Can I pay with my own card and reimburse myself later?

Yes. IRS Notice 2004-50 says there is no federal deadline if the expense happened after the HSA was established and you keep the required records. The expense cannot also be reimbursed from another source or taken as an itemized deduction.

What if I prepay for six or 12 months?

A prepay is not automatically disqualified, but it creates harder timing, allocation, refund, and cash-exposure questions. Publication 502 limits deductions for medical care paid substantially before care is received. The IRS has not published a clear HSA example for a multi-month compounded-telehealth bundle. Month-to-month is easier to match to the care and medication received.

What if the IRS asks and I cannot find the receipt?

If you cannot substantiate a distribution, the IRS may treat it as nonqualified. The amount would generally be taxable, and the 20% additional tax can apply when you are under 65. On $2,388 at a 22% federal bracket, the modeled federal income tax plus additional tax is about $1,003, before state tax or interest. Download the receipt when each charge occurs.

Is compounded semaglutide legal right now?

It can be lawful in a narrower patient-specific lane. The shortage-based enforcement-discretion periods ended in 2025. Under 503A, a valid patient-specific prescription and the restrictions on essentially copies matter; a documented change that creates a significant difference for the identified patient can matter. Semaglutide is not on the current shortage list or 503B bulks list.

Is compounded semaglutide a generic version of Ozempic or Wegovy?

No. There is no FDA-approved generic semaglutide. Compounded semaglutide is not an approved generic and is not interchangeable with Ozempic or Wegovy. FDA has issued warning letters over “generic” and equivalence-style claims.

What if I stop being eligible to contribute to an HSA?

You can still use money already in the HSA for qualified medical expenses. Losing contribution eligibility—such as leaving an HSA-qualified high-deductible health plan—stops or limits new contributions. It does not erase the account balance.

Can I use HSA funds for the telehealth visit and shipping too?

Clinical visits can qualify when they are medical care. Shipping tied to obtaining a prescribed medicine may be part of the documented charge, but bill structure matters. SHED labels provider visits and shipping eligible with a receipt; that is SHED's provider statement, not a universal IRS ruling. Ask for separate line items.

Which provider has the lowest 90-day cost?

Embody's quarterly tier has the lowest modeled three-month total at about $228, but it carries a multi-month commitment. Embody's monthly plan is $237 over 90 days and has the lowest month-to-month cash exposure we found. Both figures use the current active price schedule and should be confirmed at checkout.

Which provider has the clearest HSA paperwork?

SHED. It is the only provider in this audit with a full public help article that states card acceptance, identifies charge categories, gives receipt-download steps, and offers a route to ask for more documentation.

Can I use an FSA instead?

Possibly, but the process is different. An FSA administrator may require a claim and supporting documents, and your plan may have a run-out period, grace period, or carryover rule. Use the separate semaglutide FSA guide and check your plan document.

Does my state matter?

Yes. The clinician must be able to treat you where you are located, and the pharmacy must be able to serve your state. Confirm the exact medication and pharmacy during intake before the charge becomes nonrefundable.

What documents should I save?

Save the prescription, itemized receipt, proof of payment, visit summary or chart note showing the diagnosed condition and medical purpose, any prescriber note explaining why the compounded version was selected, the pharmacy and product label, and billing or cancellation emails. Also keep proof that the expense was not reimbursed elsewhere or deducted twice.

What are the 2026 HSA contribution limits?

For 2026, the HSA contribution limit is $4,400 for self-only coverage and $8,750 for family coverage. An eligible person age 55 or older can contribute an extra $1,000. The minimum deductible for an HSA-qualified high-deductible health plan is $1,700 self-only or $3,400 family. Contribution eligibility and expense eligibility are separate questions.

One last thing

If you take nothing else from this page, take this:

The card working does not mean the file is safe. The card failing does not mean the expense is disqualified. What gives you a defensible file is a medical purpose tied to a diagnosed condition, a receipt that identifies what you bought, and records that explain why a compounded version was chosen.

That is a small set of documents. It can take about ten minutes to request them. It is not hard—it is just that an HSA may never put a claim reviewer in front of you to ask for them.

Now you know. Get the records before you need them, then make the treatment decision with your clinician.

→ Check Embody eligibility—current semaglutide pricing starts at $79/month

Initial charge happens at checkout. Confirm the receipt process, pharmacy, formulation, cancellation date, and refund point first.

Still not sure which GLP-1 path fits your state, budget, and payment method? Take the free 60-second matching quiz.

It separates insurance from cash pay, HSA from FSA, and FDA-approved medication from compounded options.

→ Get my GLP-1 action plan

Primary sources

IRS

• IRS Publication 502, Medical and Dental Expenses
• IRS Publication 969, Health Savings Accounts and Other Tax-Favored Health Plans
• IRS Notice 2004-50, including delayed HSA reimbursement Q&A
• IRS Revenue Procedure 2025-19, 2026 HSA and HDHP limits
• IRS Form 8889

FDA and Federal Register

• FDA: GLP-1 shortage and compounding-policy timeline
• FDA: Concerns with unapproved GLP-1 drugs used for weight loss
• FDA: February 6, 2026 action statement on mass-marketed non-FDA-approved GLP-1 drugs
• Federal Register: proposed 503B bulks-list determination, 91 FR 23431
• FDA Warning Letter: MEDVi #721455
• FDA Warning Letter: Ivim #721816
• FDA Warning Letter: SkinnyRx #717989
• FDA Warning Letter: Hims & Hers #716825
• FDA Warning Letter: MyStart #714755

Provider pricing, HSA, and cancellation sources

• Embody current terms and price schedule
• Embody cancellation and refund policy
• SHED compounded semaglutide product and price tiers
• SHED HSA/FSA help center
• SHED terms
• Patiently cancellation and refund policy
• Patiently weight-loss page
• PlexusDx HSA and compounded semaglutide page
• Willow FAQ
• TrimRx terms
• TrimRx 2026 pricing page
• Ivim membership agreement
• MEDVi program page
• MEDVi cancellation and refund policy
• SkinnyRx terms
• Yucca FAQ
• Hims HSA/FSA reimbursement page
• Hims terms
• Hims & Hers March 9, 2026 strategy update
• Hers compounded semaglutide price statement
• Ro pricing
• Ro HSA/FSA receipt FAQ
• Ro free GLP-1 insurance coverage checker

Advertising self-regulation record

• NAD referral involving Willow, December 2025
• NAD reopened matter and permanent discontinuance, July 2026

Medical and tax disclaimer: This page is general information, not medical advice or tax advice. Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing. Talk to a licensed clinician about whether any GLP-1 medication is appropriate for you. Talk to a qualified tax professional about a disputed or material HSA expense. Your HSA custodian can explain its payment and reimbursement process but does not replace your responsibility for federal tax treatment.

Weight Loss Provider Guide is an independent comparison resource for GLP-1 telehealth providers.

Last verified: August 26, 2026.